Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Ubicación

MS status

Recruitment Status

Fase

Drogas

Inmunoterapia previa permitida

NCT ID

Title key word search

Fecha en que se añadió el juicio

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Fase	Date Added	Ubicación	Prior IO Allowed	CRC-directed	Status	Drogas	Etiquetas
NCT ID NCT05743036	TitleZN-c3 in Adult Participants With BRAF mutant Metastatic Colorectal Cancer	Fase Fase 1	Date Added 2023-02-24	Ubicación California, United States Kansas, United States Texas, United States Australia Alemania Hungary Italia Polonia España	Prior IO Allowed Sí	CRC-directed Sí	Status Activo, no recluta	Drogas cetuximab, encorafenib, ZN-c3	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03984578	TitleEstudio de la ventana de oportunidad en el cáncer colorrectal	Fase Fase 2	Date Added 2019-06-13	Ubicación Singapur	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Capecitabine/ 5-FU, CapeOX, Pembrolizumab, Eloxatin, Keytruda	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT05771181	TitleVitamin E Combined With Fruquintinib and Tislelizumab in Microsatellite Stabilized Metastatic Colorectal Cancer Patients	Fase Fase 2	Date Added 2023-03-16	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Aún no se ha contratado	Drogas Fruquintinib, Tislelizumab, Vitamin E	Etiquetas MSS/ MMRp
NCT ID NCT03290937	TitleUtomilumab, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Metastatic Colorectal Cancer	Fase Fase 1	Date Added 2017-09-25	Ubicación Texas, United States	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas cetuximab, Irinotecan Hydrochloride, Utomilumab	Etiquetas MSS/ MMRp
NCT ID NCT05976906	TitleUniversal Dual-target NKG2D-NKp44 CAR-T Cells in Advanced Solid Tumors	Fase Fase 1	Date Added 2023-08-04	Ubicación China	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT04483219	TitleTyrosine Kinase Inhibitor (TKI) + Anti-PD-1 Antibody in TKI-responded Microsatellite Stability/Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Adenocarcinoma.	Fase Fase 2	Date Added 2020-07-23	Ubicación China	Prior IO Allowed Sí	CRC-directed Sí	Status Unknown status	Drogas TKI ± anti-PD-1 antibody	Etiquetas MSS/ MMRp
NCT ID NCT04589845	TitleEstudio de la plataforma TAPISTRY (Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You)	Fase Fase 2	Date Added 2020-10-19	Ubicación Alabama, United States Arizona, United States California, United States Colorado, United States Delaware, United States Florida, United States Georgia, United States Idaho, United States Illinois, United States Indiana, United States Maine, United States Maryland, United States Michigan, United States Minnesota, United States Missouri, United States Montana, United States Nebraska, United States Nevada, United States New Hampshire, United States New Jersey, United States New Mexico, United States New York, United States Ohio, United States Oregon, United States Pennsylvania, United States South Carolina, United States Tennessee, United States Texas, United States Washington, United States Wisconsin, United States Australia Bélgica Brasil Canadá China Dinamarca Francia Alemania Hong Kong Israel Italia Japón Corea, República de Nueva Zelanda Polonia Portugal Puerto Rico Singapur Sudáfrica España Suiza Taiwán Reino Unido	Prior IO Allowed No	CRC-directed No	Status Reclutamiento	Drogas Alectinib, Atezolizumab, Belvarafenib, Entrectinib, Idasanutlin, Inavolisib, Ipatasertib, Pralsetinib, Trastuzumab emtansine	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT02856425	TitleTrial Of Pembrolizumab And Nintedanib	Fase Fase 1	Date Added 2016-08-04	Ubicación Francia	Prior IO Allowed No	CRC-directed No	Status Reclutamiento	Drogas Nintedanib, Pembrolizumab, Keytruda, Ofev, Vargatef	Etiquetas MSS/ MMRp
NCT ID NCT03921684	TitleEnsayo de Nivolumab con FOLFOX tras quimiorradiación en pacientes con cáncer rectal	Fase Fase 2	Date Added 2019-04-19	Ubicación Israel	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas capecitabine, mFOLFOX6, Nivolumab	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT04003792	TitleTratamiento con infusión arterial hepática de oxaliplatino en combinación con quimioterapia sistémica FOLFIRI y bevacuzimab en pacientes con metástasis colorrectales hepáticas (CRLM) sólo hepáticas: Conversión a resección completa en pacientes con CRLM sólo hepáticas inicialmente inoperables.	Fase Fase 2	Date Added 2019-07-01	Ubicación Israel	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas Bevacizumab, FOLFIRI Protocol, oxaliplatin	Etiquetas MSI-H/ MMRd, MSS/ MMRp

Showing 1 to 10 of 299 entries